NCT01818856View on ClinicalTrials.gov

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Hepatitis C, ChronicHIV Infection

Interventions

DRUG

Ritonavir withdrawal, atazanavir 200 mg/12h

DRUG

Telaprevir interactions

Trial Locations (1)

41013

Hospital Universitario Virgen del Rocio, Seville

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Hospitales Universitarios Virgen del Rocío

OTHER

NCT01818856 - Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir | Biotech Hunter | Biotech Hunter